Company / Revenue
Insight Molecular Diagnostics Inc. Revenue History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$1.9M
FY2025
5-year range
$958.0K / $2.2M
FY2021-FY2025
Trend
+25.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $958,000 to $2M over the past 2 years.
Based on SEC 10-K filings.
$2M in FY2025 with a 5-year CAGR of +9.1%.
Improved from $958,000 to $2M over the past 2 years.
Revenue over time
Growth rates
- 3-Year CAGR
- -5.1%
- 5-Year CAGR
- +9.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +9.1%, indicating consistent growth.
- In FY2025, revenue increased 25.1% year-over-year.
- Peak revenue was recorded in FY2022.
- Lowest revenue in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -7.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.9M | +25.1% |
| FY2024 | $1.5M | +56.9% |
| FY2023 | $958.0K | -56.4% |
| FY2022 | $2.2M | +80.8% |
| FY2021 | $1.2M | +0.0% |
| FY2020 | $1.2M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026